1 year service for two (2) S6 sorters and various lasers

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-24-2213462 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) FAC 2024-03 February 23, 2024

The North American Industry Classification System (NAICS) code for this procurement is 811210, Other Electronic and Precession Equipment Repair and Maintenance, with a small business size standard of $34,000,000.00. The requirement is being competed full and open competition, un-restricted and without a small business set-aside.

The Vaccine Research Center (VRC) of NIAID is seeking to procure a maintenance agreement for BD Biosciences equipment:
*See the attached for list of equipment and serial numbers.
*See the attached for service requirements. This is daily mission essential equipment and requires priority response time equal to that of a direct contract and with OEM parts and technicians.

*Note: Due to the nature of this equipment and to avoid un-necessary downtime of this equipment, a 48-hour priority status is required for this service agreement and as priority status is only available with a direct contract with BD Biosciences, quotes submitted by third-party vendors must also include a direct contract with BD Biosciences to be considered or a guarantee that priority response service is “equal to that of a direct contract with BD Biosciences.”

* Third-party vendors must include their guaranteed response time to make emergency calls made to BD Biosciences.
 
*Special note: This equipment goes through a rigorous decontamination process every time for PM and repair. The decontamination may shorten the life of the parts resulting in the possibility of replacement parts and repairs needed more often than the standard life expectancy.

Place of Performance:
NIAID
Vaccine Research Center 
40 Convent Drive
Bldg 40 
Bethesda, MD  20814 

FOB: Destination

Period of Performance: 
06/01/2024 - 05/31/2025

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following: Technical capability to meet the service requirements and price.

ATTENTION QUOTERS! BY PROVIDING AN OFFER TO THIS RFQ, IT CONFIRMS YOUR ACCEPTANCE THAT THE FOLLOWING GOVERNMENT TERMS AND CONDITIONS SHALL PREVAIL OVER THE AWARD.

The following FAR provisions apply to this acquisition: 

FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (FEB 2024)

FAR 52.204-7 System for Award Management (OCT 2018)

(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)

52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2022)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (FEB 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)

FAR 52.204-13 System for Award Management Maintenance (OCT 2018)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)

FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:  http://farsite.hill.af.mil/vffara.htm

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Submission shall be received not later than March 17, 2024 @ 4:00 EST

Offers may be e-mailed to Diana Rohlman (E-Mail/ diana.rohlman@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-24-2213462). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) 

All responsible sources may submit an offer that will be considered by this Agency.  
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Diana Rohlman at diana.rohlman@nih.gov.